Key points are not available for this paper at this time.
These pilot data suggest that a KD is suitable for even advanced cancer patients. It has no severe side effects and might improve aspects of quality of life and blood parameters in some patients with advanced metastatic tumors.
Schmidt et al. (Wed,) studied this question.